Medtronic plc logo
Medtronic plc (MDT)
Compare

Medtronic plc (MDT) Shares Outstanding: 1.28

Is Medtronic plc’s shares outstanding high or low?

Medtronic plc's shares outstanding of 1.28 is in line with its 5-year average of 1.32, near the low end of its 5-year range (1.28–1.34).

The shares outstanding for Medtronic plc (MDT) is 1.28. It is below its 12-month average by 0.15% (1.28).

MDT Shares Outstanding Chart

MDT Shares Outstanding
1.28-0.30% 1Y
Zoom

MDT Average Shares Outstanding Chart

MDT Current vs Average Shares Outstanding Chart

MDT Shares Outstanding Metrics

SHARES OUTSTANDING

1.28

SHARES OUTSTANDING AVG TTM

1.28

SHARES OUTSTANDING AVG 3Y

1.31

SHARES OUTSTANDING AVG 5Y

1.32

SHARES OUTSTANDING AVG 10Y

1.34

SHARES OUTSTANDING AVG 15Y

1.25

SHARES OUTSTANDING AVG 20Y

1.22

CURRENT VS TTM AVG

-0.15%

CURRENT VS 3Y AVG

-1.87%

CURRENT VS 5Y AVG

-2.80%

CURRENT VS 10Y AVG

-4.37%

CURRENT VS 15Y AVG

+2.58%

CURRENT VS 20Y AVG

+4.71%

Share Structure

Shares Outstanding

1.28B

Float Shares

N/A

Stock Price

$81.98

Market Cap

$105.3B

Annual Shares Outstanding History

YearWeighted Average SharesYoY Change
20261.28B-0.30%
20251.29B-3.17%
20241.33B-0.16%
20231.33B-0.94%
20221.34B-0.19%
20211.34B+0.31%
20201.34B-0.42%
20191.35B-0.76%
20181.36B-1.61%
20171.38B-2.18%
20161.41B+28.67%
20151.10B+9.32%
20141.00B-1.69%
20131.02B-3.28%
20121.05B-2.18%
20111.08B-2.61%
20101.11B-1.39%
20091.12B-0.78%
20081.13B-1.65%
20071.15B-4.55%
20061.20B-0.52%
20051.21B-0.24%
20041.21B-0.31%
20031.22B+0.49%
20021.21B+0.71%
20011.20B+0.69%
20001.19B+1.50%
19991.18B+2.34%
19981.15B+0.58%
19971.14B-

Relationship: Market Cap = Shares Outstanding × Stock Price

Key concepts:

  • Float shares: Shares available for public trading
  • Dilution: When new shares are issued, existing shareholders own less
  • Buybacks: Reduce share count, increasing EPS and ownership stake
  • Stock splits: Increase share count but don't change market cap

Medtronic plc Shares Outstanding Formula & Definition

Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Medtronic plc Shares Outstanding FAQ

What is the shares outstanding for Medtronic plc (MDT)?
The shares outstanding for MDT stock is 1.28.
Is Medtronic plc's shares outstanding high or low?
Medtronic plc's shares outstanding of 1.28 is in line with its 5-year average of 1.32, near the low end of its 5-year range (1.28–1.34).
What is the TTM average shares outstanding for Medtronic plc (MDT)?
The TTM average shares outstanding for MDT stock is 1.28.
What is the 3Y average shares outstanding for Medtronic plc (MDT)?
The 3Y average shares outstanding for MDT stock is 1.31.
What is the 5Y average shares outstanding for Medtronic plc (MDT)?
The 5Y average shares outstanding for MDT stock is 1.32.
What is the 10Y average shares outstanding for Medtronic plc (MDT)?
The 10Y average shares outstanding for MDT stock is 1.34.
What is the 15Y average shares outstanding for Medtronic plc (MDT)?
The 15Y average shares outstanding for MDT stock is 1.25.
What is the 20Y average shares outstanding for Medtronic plc (MDT)?
The 20Y average shares outstanding for MDT stock is 1.22.

Medtronic plc Shares Outstanding History

DATESHARES OUTSTANDING
2026-04-241.28
2025-04-301.29
2024-04-301.33
2023-04-301.33
2022-04-301.34
2021-04-301.34
2020-04-301.34
2019-04-301.35
2018-04-301.36
2017-04-301.38
2016-04-301.41
2015-04-301.10
2014-04-301.00
2013-04-301.02
2012-04-301.05
2011-04-301.08
2010-04-301.11
2009-04-301.12
2008-04-301.13
2007-04-301.15
2006-04-301.20
2005-04-301.21
2004-04-301.21
2003-04-301.22
2002-04-301.21
2001-04-301.20
2000-04-301.19
1999-04-301.18
1998-04-301.15
1997-04-301.14

About Medtronic plc

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Galway
95,000 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Geoffrey Straub Martha